CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSOTTI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 424
AS - Asia 273
EU - Europa 113
Continente sconosciuto - Info sul continente non disponibili 89
SA - Sud America 31
AF - Africa 11
OC - Oceania 1
Totale 942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 400
SG - Singapore 72
CN - Cina 67
IT - Italia 51
HK - Hong Kong 50
BD - Bangladesh 23
BR - Brasile 16
IQ - Iraq 14
IN - India 13
RU - Federazione Russa 13
CA - Canada 11
FR - Francia 9
GB - Regno Unito 9
DE - Germania 8
AR - Argentina 7
NL - Olanda 7
VN - Vietnam 7
VE - Venezuela 6
IE - Irlanda 4
MY - Malesia 4
PH - Filippine 4
SC - Seychelles 4
LY - Libia 3
MX - Messico 3
TR - Turchia 3
BB - Barbados 2
BG - Bulgaria 2
ES - Italia 2
FI - Finlandia 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
PK - Pakistan 2
SA - Arabia Saudita 2
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MM - Myanmar 1
MQ - Martinica 1
NP - Nepal 1
PR - Porto Rico 1
SE - Svezia 1
SV - El Salvador 1
SZ - Regno dello Swaziland 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 853
Salva come PNG Salva come JPEG
Città #
San Jose 112
Council Bluffs 61
Singapore 49
Hong Kong 41
Beijing 14
Ashburn 13
Santa Clara 13
Milan 10
Los Angeles 9
New York 8
Rome 8
Erbil 7
London 6
New Delhi 6
Chandler 5
Dallas 5
Montreal 5
Moscow 5
North Bergen 5
San Francisco 5
Ambérieu-en-Bugey 4
Jacksonville 4
The Dalles 4
Caracas 3
Chicago 3
Hanoi 3
Tampa 3
Verona 3
Wilmington 3
Atlanta 2
Baghdad 2
Belo Horizonte 2
Bologna 2
Bridgetown 2
Buffalo 2
Dublin 2
Duhok 2
Genoa 2
Helsinki 2
Ho Chi Minh City 2
Kajang 2
Las Vegas 2
Mexico City 2
Nampa 2
North Kansas City 2
Philadelphia 2
Phoenix 2
San Juan 2
Tel Aviv 2
Adamantina 1
Afragola 1
Allentown 1
Almaty 1
Amman 1
Apodaca 1
Athens 1
Bari 1
Benghazi 1
Brampton 1
Brooklyn 1
Bến Lức 1
Cambridge 1
Capaccio 1
Carmel 1
Carúpano 1
Castelar 1
Castellammare di Stabia 1
Chiquimula 1
Cipolletti 1
Clark 1
Cuenca 1
Cumanacoa 1
Dagupan 1
Dalton 1
Davenport 1
Denizli 1
Denver 1
Des Moines 1
Dhaka 1
Duque de Caxias 1
East Orange 1
East Stroudsburg 1
Falkenstein 1
Fenton 1
Ferrara 1
Figino 1
Fortaleza 1
Frankfurt am Main 1
Frutal 1
Galati Mamertino 1
Giza 1
Goiânia 1
Grain Valley 1
Haarlem 1
Haiphong 1
Hattiesburg 1
Hebei 1
Hialeah 1
Houston 1
Hyderabad 1
Totale 508
Salva come PNG Salva come JPEG
Nome #
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection 96
A case of chronic bacterial prostatitis due toMycoplasma genitalium 80
Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience 22
Implementation of HIV Pre-exposure Prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE Cohort Survey 20
Is the rate of virological failure to cART continuing to decline in recent calendar years? 16
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 16
The burden of liver disease in human immunodeficiency virus-infected patients 15
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 15
Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 15
Medical and psychological needs for injectable long-acting cabotegravir as pre-exposure prophylaxis 15
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 14
A comparison of tenofovir predose concentrations in generic pre-exposure prophylaxis formulations: A short communication 14
Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1 14
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 14
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients 14
Sexually Transmitted Hepatitis (cap. 13) 14
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 13
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period 13
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy 13
Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data 13
Risk factors for community-acquired bacterial meningitis: men who have sex with men (MSM) as a population at risk for meningococcal nasopharyngeal carriage 13
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 13
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 12
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 12
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 12
Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP 12
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 12
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 11
Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report 11
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 11
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 11
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 11
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 11
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 11
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients 11
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 11
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis 11
Correspondence: the recommended resistance-guided treatment of Mycoplasma genitalium infection in symptomatic individuals is not feasible in many Italian settings 10
Optimizing treatment in HIV/HCV coinfection 10
Hepatitis A Virus in men who have sex with men: Need for awareness and vaccination 9
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 9
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation 9
Outbreak of Acute Hepatitis A involving young men in Lombardy region, Italy: Risk factors, clinical and virological characteristics 9
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 9
The use of intrahepatic portosystemic shunt in HIV positive patients : A retrospective multicentric study 9
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 8
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 8
A cluster of patients with recombinant B/F HIV-1 infection: Epidemiological, clinical, and virological aspects 8
Efficacy of sofosbuvir-based therapies in HIV/HCV infected patients and persons who inject drugs 8
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 8
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study 8
High prevalence of anal papillomavirus infection in men who have sex with men PrEP users 8
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy 8
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 7
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 7
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 7
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 7
Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV 7
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 7
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 7
HIV education and counselling using Facebook: A possible new approach 6
Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject 6
Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report 6
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 6
Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA) 6
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 6
Outbreak of acute hepatitis A involving young men in Lombardy Region, Italy: risk factors, clinical and virological characteristics 6
Treatment of hepatitis C virus genotype 1-infected patients: Mission accomplished? 6
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 6
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 5
Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results 5
Infezioni del fegato e delle vie biliari (cap.12) 5
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 5
Clinical management of ESBL-producing Enterobacteriaceae: The insidious role of fluoroquinolones 5
Feasibility of all-oral anti-HCV treatment during DHAP chemotherapy and autologous stem cell transplantation for T-cell lymphoma 5
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 4
Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy 4
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays 4
Nevirapine-based regimens in routine clinical settings: Results from a large italian cohort of HIV-1 infected adults 3
Hepatocellular carcinoma in HIV hepatitis C virus 3
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 2
Enterococcus gallinarum endocarditis in a diabetic patient 2
Human immunodeficiency virus and hepatitis c virus coinfection: The agenda is full while waiting for new drugs 2
FDG-PET/CT imaging in the diagnosis of HIV-associated multicentric castleman disease: Something is still missing 2
Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: A casecontrol study 1
Electrophysiological Adverse Effects of Direct-Acting Antivirals in Patients With Chronic Hepatitis C 1
Top topics in HCV research arena 1
Totale 942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.037
article - articoli 10.801
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 236
Totale 22.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 1 0 0 0 0 0 0 1 0 0 2
2022/202316 1 0 2 1 2 4 1 1 2 0 2 0
2023/20246 0 0 0 2 0 2 1 0 0 0 1 0
2024/202522 1 1 0 3 1 1 0 1 3 0 1 10
2025/2026623 5 2 2 7 13 3 3 1 53 441 32 61
2026/2027265 206 59 0 0 0 0 0 0 0 0 0 0
Totale 942